1
/
of
0
FDA FAERS Adverse Event Reports for WINREVAIR (sotatercept) from Jan–Feb 2025
FDA FAERS Adverse Event Reports for WINREVAIR (sotatercept) from Jan–Feb 2025
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: I would like to request full reports of any and all adverse events reported to the FAERS database for WINREVAIR (branded name / marketed by Merck & Co., Inc.) or sotatercept-csk (generic name) between January 1, 2025, and February 28, 2025. Please provide the documents electronically if possible.
Tags: Pharma, FAERS, 2025
Tags: Pharma, FAERS, 2025
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details